Acquired Immunodeficiency Syndrome: all 3,037 studies

Page 21 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.

• Progression of HIV-Disease Under Low Dose CorticosteroidsCompletedNCT01299948Phase 2
• Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus DarunavirCompletedNCT01294761Not applicable
• Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsCompletedNCT01290211Phase 1
• Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic CirrhosisCompletedNCT01289951Phase 1
• The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive IndividualsStatus unknownNCT01289652
• Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual StruggleCompletedNCT01289444Not applicable
• Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate VaccineCompletedNCT01285141Phase 1
• Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infectionStatus unknownNCT01273142
• A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult SubjectsWithdrawnNCT01273103Phase 1
• The Study of the Prevalence of Helicobacter Pylori Infection Among HIV/AIDS CohortCompletedNCT01261208
• Effects of an Evidence Service on Community-based AIDS Service Organizations' Use of Research EvidenceStatus unknownNCT01257724Not applicable
• Study of SystemCHANGE-HIVCompletedNCT01256814Not applicable
• Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase ICompletedNCT01253850
• Adherence, Improvement Measure (AIM) SystemCompletedNCT01252212Phase 3
• Cameroon Mobile Phone SMS TrialCompletedNCT01247181Not applicable
• Study Targeting Affect RegulationCompletedNCT01237366Phase 1/2
• Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female VolunteersCompletedNCT01231542Phase 1
• GSK1349572 Hepatic Impairment StudyCompletedNCT01231529Phase 1
• Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)Status unknownNCT01230580Phase 4
• Multi-vitamins, HAART and HIV/AIDS in UgandaCompletedNCT01228578Phase 3
• Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)CompletedNCT01227590Phase 1
• Family Planning Through Dairy CooperativesCompletedNCT01226433
• Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy SubjectsCompletedNCT01220232Phase 1
• A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy SubjectsCompletedNCT01214993Phase 1
• Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected PatientsStatus unknownNCT01213186Phase 2
• Chinese Network of Pediatric Antiretroviral TherapyCompletedNCT01210924
• A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435CompletedNCT01209117Phase 1
• GSK1349572 Drug Interaction Study With Fosamprenavir/RitonavirCompletedNCT01209065Phase 1
• Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
• The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model SystemCompletedNCT01206933
• HIV Indicator Diseases Survey Across Europe - UK ArmStatus unknownNCT01196468
• Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-upCompletedNCT01196273
• A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.TerminatedNCT01195974Phase 1
• Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen FailureCompletedNCT01189695Phase 4
• The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine ResistanceCompletedNCT01187719Phase 2
• Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male CircumcisionCompletedNCT01186575Not applicable
• Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected PopulationCompletedNCT01180075
• Epidermal Nerve Fiber Density, Fat and Mitochondrial Parameters in Thai HIV+ Patients on d4T and HIV- PatientsCompletedNCT01178684
• Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?CompletedNCT01176409Phase 3
• A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear CellsWithdrawnNCT01173510Phase 4
• Intrauterine Insemination In HIV-Discordant CouplesTerminatedNCT01173276Not applicable
• HIV/AIDS, Severe Mental Illness and HomelessnessCompletedNCT01172704Phase 2
• Impact of Nutrition Intervention on HIV/AIDS Infected PatientsCompletedNCT01171495Phase 3
• Computer-Assisted Tailored Cue-card Health [CATCH] StudyCompletedNCT01170741Phase 1
• A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDYWithdrawnNCT01160575
• Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDSCompletedNCT01158443Phase 4
• Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral DensityCompletedNCT01153217Phase 3
• The Effects of Spirulina Platensis on Insulin Resistance in HIV-infected PatientsCompletedNCT01141777Not applicable
• Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in UgandaCompletedNCT01140633
• Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsTerminatedNCT01140412Phase 1
• A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.CompletedNCT01138072Phase 1
• Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful NeuropathyCompletedNCT01135251Phase 2
• Stonewall Treatment Evaluation ProjectCompletedNCT01129401Phase 1/2
• A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected PeopleTerminatedNCT01123915Phase 1
• Evaluation of a Computer-Based System Using Cell Phones for HIV People in PeruCompletedNCT01118767Not applicable
• Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women PrisonersCompletedNCT01111721Not applicable
• A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)CompletedNCT01106638Phase 3
• A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult SubjectsCompletedNCT01101893Phase 1
• GSK1349572 Drug Interaction Study With EfavirenzCompletedNCT01098526Phase 1
• GSK1349572 Relative Bioavailability StudyCompletedNCT01098513Phase 1
• Long-term Follow-up of Participants From Studies Evaluating GSK HIV VaccineCompletedNCT01092611Phase 1
• TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected PatientsCompletedNCT01090648Phase 1
• Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in AfricaCompletedNCT01088516Phase 4
• Safety of Cotrimoxazole in HIV- and HAART-exposed InfantsCompletedNCT01086878Phase 4
• A Computer-Based Parent/Adolescent HIV Communication Intervention for LatinosCompletedNCT01084421Not applicable
• Reducing HIV Risk Among Mexican YouthCompletedNCT01084395Not applicable
• PENTA Fosamprenavir StudyCompletedNCT01077635
• Fractures Stratified by HIV and Antiretroviral Therapy (ART) StatusCompletedNCT01077557
• HIV Vaccine Study in HIV Positive PatientsCompletedNCT01071031Phase 1
• Community-based Accompaniment With Supervised Antiretrovirals in Lima, PeruCompletedNCT01070017Phase 3
• Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy VolunteersCompletedNCT01068925Phase 1
• Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected PatientsStatus unknownNCT01067417Phase 2
• The Impact of Short Message Services (SMS) on ARV Adherence in Western KenyaCompletedNCT01058694Not applicable
• HIV Treatment and CVD EventsCompletedNCT01054638
• Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv SettingCompletedNCT01053598
• Notification of Donors With Positive Microbiology MarkersCompletedNCT01050881
• Pre-Exposure Prophylaxis Using TMC278LATerminatedNCT01049932Phase 1/2
• A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The BodyCompletedNCT01045317Phase 1
• Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine HypersensitivityCompletedNCT01044810
• Sexually Transmitted Infections Among African American Women Who Have Sex With WomenCompletedNCT01043081
• Medications for Chronic HIV: Education and CollaborationCompletedNCT01038076Not applicable
• Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid TestCompletedNCT01032902
• Self-Managing HIV and Chronic DiseaseCompletedNCT01032824Not applicable
• Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 InfectionCompletedNCT01032408Phase 3
• A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761CompletedNCT01031472Phase 1
• Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy VolunteersCompletedNCT01027182Phase 1
• A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral TherapyTerminatedNCT01026727Phase 2
• Integrating Family Planning Into Postabortion CareCompletedNCT01020552
• Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected PatientsStatus unknownNCT01013987Phase 4
• A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In IndiaNo longer availableNCT00992654
• Europe-Africa Research Network for Evaluation of Second-line TherapyCompletedNCT00988039Phase 3
• Genotype Based Personalized Prescription of NevirapineCompletedNCT00986063Phase 4
• Pilot Assessment of Lopinavir/Ritonavir and MaravirocTerminatedNCT00981318Phase 4
• Profile of HIV Seropositive PatientsCompletedNCT00981279
• The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS PatientsStatus unknownNCT00974519Not applicable
• Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)Status unknownNCT00974454Not applicable
• Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV PatientsStatus unknownNCT00974285Not applicable
• Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected PatientsCompletedNCT00973466
• Mentor Mothers: A Sustainable Family Intervention in South African TownshipsCompletedNCT00972699Phase 2
• A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, AfricaCompletedNCT00971230Phase 1/2

← Acquired Immunodeficiency Syndrome overview